Testing the safety of multiple doses of BWC0977 in healthy people
Part of Infections clinical trials.
This study tests an experimental antibiotic called BWC0977 to see if it is safe and well-tolerated when given as single and multiple doses. It is for healthy volunteers to understand how the drug behaves in the body before moving to patient trials.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 55 years old and in good general health.
- Your body mass index (BMI) should be between 19 and 30, and weight between 55 and 100 kg.
- You must not have any chronic diseases or significant health issues like heart, liver, or kidney problems.
- You agree to use effective contraception if you could become pregnant or get someone pregnant, and follow other restrictions.
- You must not smoke, use nicotine, or have used antibiotics or certain medications recently.
- You must be willing to stay at the research unit for study visits and avoid strenuous activities.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational antibiotic called BAL2420 to see if it is safe and how the body processes it. Healthy volunteers are needed to help determine the right dose before it can be studied in people with infections.
This study tests a new medicine called BW-40202 for the first time in people. It is for healthy volunteers to see if the drug is safe and how it works in the body. You must be in good general health to take part.
This study tests a new medicine (BI 3776528) in healthy men to see how well different doses are tolerated. It helps researchers find the safest dose before testing in people with a condition.
This trial tests a new medicine, BW-50218, in healthy volunteers to see how safe it is and how the body processes it. If you are generally healthy and meet the specific requirements below, you may be able to help with early research on this potential treatment.
This trial tests how safe and tolerable different doses of the study drug BI 3814916 are in healthy adults. It helps find the right dose for future studies.
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
Hear when a new Antimicrobial Drug Resistance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.